Technology News and Research

RSS

USAID Administrator issues statement on CAPRISA 004 trial for preventing HIV infection in women

USAID is proud to be the major funder of the first-ever proof of concept that a microbicide can effectively and safely reduce the transmission of HIV from men to vulnerable women. An achievement of this magnitude could not have been possible without collaboration among governments, scientists, communities, and individual women at risk of HIV.

20 Jul 2010

Ratio secures equity financing

Ratio, Inc. has secured equity financing from regional angel investors and angel networks. The groups participating in the round include Wisconsin Investment Partners, The Golden Angels Network, Stateline Angels, and Central Illinois Angels. The company is keeping the round of financing open for 120 days and actively pursuing further investment.

20 Jul 2010

LRGHealthcare deploys Aruba's application-aware 802.11n Wi-Fi networks for clinical mobility needs

Aruba Networks, Inc., a global leader in distributed enterprise network solutions, today announced that LRGHealthcare (LRGH), a healthcare charitable trust based in New Hampshire, has deployed Aruba's application-aware 802.11n Wi-Fi networks to address growing clinical mobility needs throughout the Lakes Region General Hospital, Franklin Regional Hospital, and associated clinics in the cities of Lanconia, Franklin, Gilford, and Meredith.

20 Jul 2010

Cellectis bioresearch introduces new technology to develop cell-based assays for HTS studies

Cellectis bioresearch, a specialist in genome customization and a subsidiary of Cellectis, today announced the publication of a scientific study describing a novel method, based on meganuclease-driven targeted integration, for the generation of stable cell lines compatible with high throughput screening (HTS).The study demonstrated Cellectis bioresearch's technology to be faster, more reliable and efficient in deriving cell-based assays for HTS studies than classical methods.

20 Jul 2010

Univfy, Stanford scientists develop first validated prognostic test for predicting IVF live birth outcomes

Univfy, a pioneer in the development of personalized in vitro fertilization (IVF) prognostic tools, announced today the publication of new research findings in the journal Proceedings of the National Academy of Sciences (PNAS) by its founding scientific team and clinical collaborators from Stanford University.

20 Jul 2010

Combined technologies offer promise for detecting colon cancer in women

A team led by a Northwestern University biomedical engineer has found that combining novel optical technologies with a common colon cancer screening test may allow doctors to more accurately detect the presence of colon cancer, particularly in women.

20 Jul 2010

Low radiation CT scans now at Saint Francis Hospital

Patients requiring a CT scan at Saint Francis Hospital will now be exposed to up to 40 percent less radiation than traditional CT scans. The hospital has acquired state-of-the-art GE™ scanning equipment featuring Adaptive Statistical Iterative Reconstruction (ASiR) that uses an advanced image reconstruction technique that makes it possible to dramatically reduce radiation dose without compromising image quality.

20 Jul 2010

John Theurer Cancer Center to acquire TrueBeam system for treating cancer patients

In a promising development for cancer patients in New Jersey and surrounding areas, the John Theurer Cancer Center at Hackensack University Medical Center announced today that it will be the first cancer center in New Jersey to acquire an innovative system that enables a radically different approach to treating cancer with image-guided radiotherapy known as the TrueBeam- system.

20 Jul 2010

DEKA Medical announces availability of new SmartXide DOT HP Fractional CO2 laser

DEKA Medical announced today the immediate availability of the High-Powered SmartXide DOT. The new SmartXide DOT HP Fractional CO2 laser, with average power of 50W, can attain irradiance of up to 250W of power with each pulse. This makes the new SmartXide DOT HP the most powerful superpulse CO2 laser available to aesthetic physicians.

19 Jul 2010

Competitive Technologies anticipates $1M revenue from sales of Calmare Pain Therapy Treatment

Competitive Technologies, Inc. today announced it expects revenue from sales of its Calmare® Pain Therapy Treatment for the fourth quarter of fiscal 2010 to be about $1 million, nearly double that of the prior quarter. The Company expects significant additional growth in Calmare medical device sales in upcoming quarters resulting from the growing U.S. sales force of over 35 sales representatives.

19 Jul 2010

Pharma industry leaders reduce R&D time, costs with aspenONE Process Development software

Aspen Technology, Inc., a leading provider of software and services to the process industries, today announced that GlaxoSmithKline, AstraZeneca and other pharmaceutical industry leaders are reducing their research and development time and costs using newly patented technology that is part of AspenTech's aspenONE Process Development for Pharmaceuticals software.

19 Jul 2010

Bionas launches new Bionas adcon reader for impedance-based, cellular analysis

Bionas GmbH announces the launch of its new Bionas® adcon reader for impedance-based, cellular analysis. The Bionas adcon reader technology is based on real-time monitoring of cellular impedance, thus giving real-time data about cell adhesion, membrane integrity, cellular morphology and cell proliferation for applications in toxicology, oncology, receptor signaling as well as the quality management of cells.

19 Jul 2010

IBA Dosimetry to showcase Blue Phantom[2] radiation therapy commissioning solution with LDA-99SC at AAPM

IBA Dosimetry, member of IBA Group, will showcase its latest innovation in radiation therapy commissioning solutions, the Blue Phantom[2] water phantom equipped with advanced Linear Diode Array technology (LDA-99SC), at the American Association of Physicists in Medicine Annual Meeting in Philadelphia, July 18 - 22, 2010.

19 Jul 2010

e-MDs selected for IFMC's HITREC Preferred Vendor List

e-MDs, an industry leader in the development and implementation of electronic health record (EHR) and practice management (PM) solutions, announced they have been chosen for the IFMC's Health Information Technology Regional Extension Center (HITREC) Preferred Vendor List. The list represents the best products designed to help smaller practices and clinics achieve meaningful use of EHRs.

19 Jul 2010

Microarrays acquired from Vanderbilt University

Microarrays, Inc. (MI), an innovator of array-based technologies for biological research, detection and diagnostics, today announced that the company's management team and a group of independent investors have purchased MI from Vanderbilt University. The new company structure will allow MI to more quickly and nimbly respond to client's rapidly expanding needs, especially within the diagnostic and health care arenas.

19 Jul 2010

Phase II data on Genetic Immunity's DermaVir vaccine to be presented at XVIII International AIDS Conference

Genetic Immunity, a US/Hungarian biopharmaceutical company developing nanomedicine-based immunotherapies for HIV/AIDS and other chronic diseases, is releasing Phase II data on the Company's novel DermaVir therapeutic vaccine for HIV/AIDS during the XVIII International AIDS Conference this week in Vienna, Austria. DermaVir, the first dendritic cell-targeting topical HIV vaccine candidate, employs nanotechnology to induce multi-faceted and long-lived immune responses capable of eliminating HIV infected cells.

19 Jul 2010

Study evaluates immunization benefits of dissolving microneedles

A new vaccine-delivery patch based on hundreds of microscopic needles that dissolve into the skin could allow persons without medical training to painlessly administer vaccines - while providing improved immunization against diseases such as influenza.

19 Jul 2010

Researchers to receive $1.2M from Susan G. Komen for the Cure for breast cancer research

Four researchers from Detroit, Michigan's Barbara Ann Karmanos Cancer Institute and Wayne State University will receive a total of $1.2 million from Susan G. Komen for the Cure to help advance research to better detect, prevent and eliminate breast cancer. The $1.2 million awarded to these outstanding scientists is part of the $59 million portfolio of research grants that Susan G. Komen for the Cure has awarded this year alone to scientists across the globe to help accelerate innovative breast cancer research.

17 Jul 2010

SuiteMed applauds HHS final rules on "meaningful use" of EHR

SuiteMed, LLC applauds the long-awaited final rules from the US Health and Human Services Department on "Meaningful Use" of an Electronic Health Record.

17 Jul 2010

Low-dose method of performing CT heart scans developed at Porter Adventist Hospital

As warnings and concern increase over the health risks of commonly used scanning tests involving high doses of radiation, radiologists and scientists are seeking ways to improve the safety of the tools they use in diagnosing disease.

17 Jul 2010

Technology News and Research

USAID Administrator issues statement on CAPRISA 004 trial for preventing HIV infection in women

Ratio secures equity financing

LRGHealthcare deploys Aruba's application-aware 802.11n Wi-Fi networks for clinical mobility needs

Cellectis bioresearch introduces new technology to develop cell-based assays for HTS studies

Univfy, Stanford scientists develop first validated prognostic test for predicting IVF live birth outcomes

Combined technologies offer promise for detecting colon cancer in women

Low radiation CT scans now at Saint Francis Hospital

John Theurer Cancer Center to acquire TrueBeam system for treating cancer patients

DEKA Medical announces availability of new SmartXide DOT HP Fractional CO2 laser

Competitive Technologies anticipates $1M revenue from sales of Calmare Pain Therapy Treatment

Pharma industry leaders reduce R&D time, costs with aspenONE Process Development software

Bionas launches new Bionas adcon reader for impedance-based, cellular analysis

IBA Dosimetry to showcase Blue Phantom[2] radiation therapy commissioning solution with LDA-99SC at AAPM

e-MDs selected for IFMC's HITREC Preferred Vendor List

Microarrays acquired from Vanderbilt University

Phase II data on Genetic Immunity's DermaVir vaccine to be presented at XVIII International AIDS Conference

Study evaluates immunization benefits of dissolving microneedles

Researchers to receive $1.2M from Susan G. Komen for the Cure for breast cancer research

SuiteMed applauds HHS final rules on "meaningful use" of EHR

Low-dose method of performing CT heart scans developed at Porter Adventist Hospital

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News